Category Archives: Blog

Obesity Is a Brain Disease

In the U.S., 41.9% of adults are considered obese, with prevalence increasing from significantly in recent decades.1 What’s driving this public health epidemic is the burning question, with a wide range of factors, from ultraprocessed foods and linoleic acid to environmental chemicals, likely playing prominent roles. In a “60 Minutes” episode hosted by Lesley Stahl,2… Read More »

FDA Gives Accelerated Approval for Risky Alzheimer’s Pill

The U.S. Food and Drug Administration granted accelerated approval for the Alzheimer’s disease drug lecanemab (Leqembi). The drug, a monoclonal antibody, binds to amyloid beta in the brain. An 18-month study published in the New England Journal of Medicine1 found Leqembi reduced markers of amyloid in early Alzheimer’s disease and led to “moderately less decline”… Read More »